After AI express, some investors ask questions on the investor interaction platform: why has the company’s nucleic acid detection agent registered in China failed all the time? Is it because the detection effect is unstable?
Getein Biotech Inc(603387) (603387. SH) said on the investor interaction platform on January 21 that the company applied for IgG / IgM antibody detection kit in China, not nucleic acid detection kit. Due to the small sample size in China and slow progress, the company has not suspended the application for the time being and is still actively applying. Covid-19 detection product is only a part of many products of the company, Investors are also invited to pay more attention to the development of the company’s main products
